Human CD30/TNFRSF8 F(ab')2 (Research Grade Brentuximab Biosimilar) Antibody, Novus Biologicals™

Human Monoclonal Antibody

Catalog Number	Mfr. No.	Quantity
MAB129FAB21	R&D Systems MAB11129FAB2100	100 μg
MAB29FAB2SP	R&D Systems MAB11129FAB2SP	25 μg

Description

CD30/TNFRSF8 Monoclonal antibody specifically detects CD30/TNFRSF8 in Human samples. It is validated for Flow Cytometry

Specifications

• Antigen: CD30/TNFRSF8
• Dilution: Flow Cytometry 0.25 ug/mL
• Classification: Monoclonal
• Form: Purified
• Regulatory Status: RUO
• Formulation: Lyophilized from a 0.2 μm filtered solution in PBS with Trehalose. *Small pack size (SP) is supplied either lyophilized or as a 0.2 μm filtered solution in PBS.
• Gene ID (Entrez): 943
• Isotype: IgG1
• Purification Method: Protein A or G purified from cell culture supernatant
• Content And Storage: Use a manual defrost freezer and avoid repeated freeze-thaw cycles. 12 months from date of receipt, -20 to -70 °C as supplied. 1 month, 2 to 8 °C under sterile conditions after reconstitution. 6 months, -20 to -70 °C under sterile conditions after reconstitution.

• Clone: Hu8F2
• Applications: Flow Cytometry
• Conjugate: Unconjugated
• Host Species: Human
• Target Species: Human
• Gene Alias: CD30, CD30 antigen, CD30KI-1, CD30L receptor, cytokine receptor CD30, D1S166EKi-1, Ki-1 antigen, Lymphocyte activation antigen CD30, TNFRSF8, tumor necrosis factor receptor superfamily member 8, tumor necrosis factor receptor superfamily, member 8
• Immunogen: Human CD30/TNFRSF8
• Primary or Secondary: Primary
• Reconstitution: Reconstitute at 0.5 mg/mL in sterile PBS.